Abadies, Jad Zaniyah Zakiyah M.
HRN: 21-63-17 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/23/2022
07/30/2022
IV
30mg
Q24h
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes